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Transient gene expression (TGE) in mammalian cells is a method of rapidly generating
recombinant protein material for initial characterisation studies that does not require
time-consuming processes associated with stable cell line construction. High TGE
yields are heavily dependent on efficient delivery of plasmid DNA across both the
plasma and nuclear membranes. Here, we harness the protein nucleoside diphosphate
kinase (NDPK-A) that contains a nuclear localisation signal (NLS) to enhance DNA
delivery into the nucleus of CHO cells. We show that co-expression of NDPK-A
during transient expression results in improved transfection efficiency in CHO cells,
presumably due to enhanced transportation of plasmid DNA into the nucleus via the
nuclear pore complex. Furthermore, introduction of the Epstein Barr Nuclear Antigen-
1 (EBNA-1), a protein that is capable of inducing extrachromosomal maintenance,
when coupled with complementary oriP elements on a transient plasmid, was utilised
to reduce the effect of plasmid dilution. Whilst there was attenuated growth upon
introduction of the EBNA-1 system into CHO cells, when both NDPK-A nuclear
import and EBNA-1 mediated technologies were employed together this resulted in
enhanced transient recombinant protein yields superior to those generated using either
approach independently, including when expressing the complex SARS-CoV-2 spike
(S) glycoprotein.
Keywords: transient gene expression, nuclear localisation signal, nucleoside diphosphate kinase, Chinese
hamster ovary cells, Epstein Barr Nuclear Antigen-1, SARS-CoV-2 spike protein
INTRODUCTION
Chinese hamster ovary (CHO) cells are the most commonly utilised expression hosts for the
production of recombinant biotherapeutic proteins such as monoclonal antibodies (mAbs) as
they are able to generate complex, multi-domain, multi-chain proteins with human-like post-
translational modifications (Godfrey et al., 2017). Furthermore, the number of commercial
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recombinant products in the clinic has consistently increased in
recent years largely due to an increase in the number of mAb
approvals but also as a result of the emergence of novel format
molecules such as Fc-fusion proteins and bispecific antibodies
(Walsh, 2018). Technologies and processes underpinning the
generation of recombinant material in CHO cells have been
extensively developed enabling manufacturers to achieve product
titres greater than 5 g/L of mAb (Marichal-Gallardo and Álvarez,
2012; Budge et al., 2019). Despite these considerable advances,
the processes required to stably integrate genes of interest into
a CHO host cell chromosome followed by screening, selection
and adaption of a high yielding clone which is stable in both
product quality and productivity of a desired molecule takes up
to 12 months (Wurm, 2004). The generation of stable clonal cell
lines is time consuming and not always required during early
drug discovery processes where it may be necessary to rapidly
assess multiple potential therapeutic targets. Instead, transient
gene expression (TGE) is often the favoured production platform
in this scenario since it is possible to generate material for
initial characterisation studies in as little as 1–2 weeks. It is also
preferable to employ the same production host to transiently
generate therapeutic candidates as will be used to stably generate
the final product. For example, this can give greater confidence
of obtaining similar post-translational modifications and product
properties in transiently generated material as in stably generated
material to ensure that candidates evaluated early in the drug
discovery process are indicative of the final clinical molecule
(Povey et al., 2014).
In comparison to stable production, recombinant titres from
TGE are typically compromised in favour of speed and there are a
number of limitations that are specific to transient platforms; not
least of which is the requirement for efficient DNA delivery into
the nucleus of the host. Migration of plasmid DNA (pDNA) to the
nucleus without being degraded is vital to produce recombinant
material since it is the site of transcription of the recombinant
DNA to generate mRNA. Although many chemical and physical
transfection methods have been developed to transfer DNA
across the cell membrane into the cytoplasm, the process by
which exogenous DNA subsequently reaches the nucleus is
not well defined. Entry of pDNA into the nucleus has been
shown to be maximal in proliferating cells and is thought to
be aided by the disassembly of the nuclear envelope during
mitosis which removes the nuclear membrane barrier (Dean
et al., 2005). Alternatively, nuclear import of pDNA can be
facilitated by a signal mediated pathway through the nuclear
pore complex (NPC) in non-dividing cells, as is conventional
for macromolecular exchange between the cytoplasm and the
nucleus (Gasiorowski and Dean, 2003). Delivery of molecules
from the cytoplasm to the nucleus through the NPC is facilitated
by binding of importin which, in turn, delivers cargo in a
Ran/GTP dependent mechanism (Pemberton and Paschal, 2005).
The rate of import of pDNA through the NPC is largely
dependent on plasmid size and structure, i.e., supercoiled pDNA
more readily traverses the nuclear membrane than linear DNA. It
has been shown that only 0.1% of naked DNA or 1% of polymer
attached DNA migrates into the nucleus following microinjection
into the cytoplasm in COS7 cells (Pollard et al., 1998).
Enhancement of nuclear import of transfected pDNA has been
reported through two major chaperone mediated approaches.
Firstly, proteins which bind to pDNA and contain nuclear
localisation signals (NLSs) have been employed and form a
complex with importin facilitating the migration of pDNA
into the nucleus through the nuclear pore complex (NPC)
(Subramanian et al., 1999; Zanta et al., 1999; Gourbatsi et al.,
2006). Similarly, the inclusion of specific nucleotide sequences,
known as DNA nuclear target sequences (DTSs), in pDNA
can bind to proteins that bind DTSs and contain endogenous
NLSs, facilitating nuclear import through the NPC (Dean,
1997). Nucleoside diphosphokinase A (NDPK-A) and Visual
Homeobox 2 (Chx10) transcription factors have been identified
as cytoplasmic NLS containing proteins capable of chaperoning
pDNA in non-dividing HeLa cells (Munkonge et al., 2009).
Munkonge et al. have also reported that the inclusion of NDPK-
A and Chx10 binding sequences (BS) adjacent to the SV40 DTS
can increase nuclear import of pDNA (Munkonge et al., 2009).
Interestingly, additional roles of NDPK-A include activation of c-
myc transcription and the phosphorylation of GDP to GTP where
the phosphate used to enable this reaction is sequestered from
an ATP molecule (Dzeja and Terzic, 2003). This is of particular
interest in the context of nuclear import, as GTP is required for
the migration of cargo through the NPC.
Another major potential bottleneck in TGE derives from
the inability of mammalian cells to replicate and maintain
extrachromosomal non-viral pDNA throughout culture. This
results in dilution of pDNA in a transient setting over time as
cells divide in culture and, in turn, can result in limited product
yields. The Epstein Barr Virus (EBV) possesses cellular machinery
that facilitates replication of its genome in a mammalian host
cell (Yates et al., 1985). Successful approaches to enhance TGE
yields have focussed on the identification, introduction and
optimisation of the necessary EBV derived components to induce
extrachromosomal maintenance in transient expression hosts
(Yates et al., 1985; Durocher et al., 2002; Backliwal et al., 2008;
Daramola et al., 2014). A key component of this system is the
Epstein Barr Nuclear Antigen-1 (EBNA-1) protein which, along
with a recent discovery of a functional truncated derivative,
has been shown to be responsible for partitioning of pDNA
with the host chromosome (Durocher et al., 2002). The EBV
origin of replication, oriP, DNA sequence is required on the
expression plasmid for partitioning, but also facilitates the
replication of pDNA through “hijacking” of the endogenous
machinery that occurs simultaneously to host chromosome
replication. Furthermore, two sequences have been identified
within the oriP region which are involved in EBNA-1 mediated
replication. Firstly, a family of repeats (FR) region (consisting
of 20 imperfect 30 bp repeats) is the minimal essential region
for EBNA-1 partitioning and a dyad symmetry (DS) region
(consisting of four 16 bp palindromic repeats contained within
a 140 bp sequence) which enhances EBNA-1 binding (Yates et al.,
2000). Introduction of the EBNA-1 mediated system has generally
proved more successful in human embryonic kidney (HEK) cells
(also employed to produce biotherapeutics) than CHO cells,
which is not unexpected since EBV natively infects humans but
not rodents (Krysan and Calos, 1993; Daramola et al., 2014).
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Here we describe two cell engineering approaches to overcome
bottlenecks specific to TGE and enhance transient recombinant
protein production from CHOK1SV and CHOK1SV GS-KO
cells. Firstly, we show that NDPK-A and Chx10 can be
overexpressed in CHO cells to improve nuclear import of
pDNA and secondly that EBNA-1 mediated extrachromosomal
maintenance system can be employed to improve recombinant
titres in combination with the nuclear import proteins.
Importantly, we show that these engineering approaches, when
employed simultaneously, enhance TGE yields beyond the
capacity that either technology offers alone when expressing a
model IgG4 monoclonal antibody or the SARS-CoV-2 spike (S)
protein in CHO cells. Recombinant SARS-CoV-2 S protein is a
key reagent used in the production of diagnostics for the virus,
against which antibodies are raised for diagnostics, and the main
target to date for vaccine development for COVID-19 (Pollet
et al., 2021). The TGE technologies outlined herein have thus
been employed to increase transient yields of the difficult-to-
express trimeric SARS-CoV-2 S protein, highlighting the utility
of this platform to rapidly produce such molecules.
MATERIALS AND METHODS
Cloning and Construction of Vectors for
Cell Line Engineering and Recombinant
Protein Expression
Qiagen’s RNeasy kit was used to isolate RNA from 1 × 106
CHOK1SV cells (Lonza Biologics) and subsequently used
to generate cDNA using M-MLV transcriptase (Promega)
as per the manufacturers’ instructions. NDPK-A and Chx10
gene sequences were amplified using the polymerase chain
reaction (PCR) with the cDNA as the reaction template.
The primers designed to amplify NDPK-A and Chx10 were
based on NCBI sequence accession numbers XM_027424319.2
and XM_003505140.3, respectively. The primers were also
designed to add AscI and XhoI restriction sites at the 5′
and 3′ ends of the gene sequences, respectively, to facilitate
cloning into proprietary Lonza vectors containing an eGFP
reporter or glutamine synthetase (GS) gene (for use as a
selection marker). The oligonucleotides used were (restriction
site sequences added are underlined); NDPK-A Forward
5′-TATGGCGCGCCATGGCCAACAT-3′ and Reverse 5′-
ATACTCGAGTCACTCATAGATCCAGTTTTGTGCACAGCT-
3′; Chx10 Forward 5′-TATGGCGCGCCATGACGGGGAA-3′
and Reverse 5′-ATACTCGAGCTAGGCGATGTCCTCCAGCTG-
3′. A schematic of the vectors constructed in this study is shown
in Supplementary Figure 1.
Complementary binding sequences (BS) sequences for the
NLS proteins were also identified (Munkonge et al., 2009)







by annealing complementary oligonucleotides. BamHI
restriction sites (underlined) were added to these sequences to
facilitate cloning into the eGFP-containing vector and previously
constructed vectors containing the appropriate NLS containing
genes (schematics shown in Supplementary Figure 1).
In order to introduce the EBNA-1 mediated
extrachromosomal maintenance system into CHO cells, a
truncated EBNA-1 gene and oriP (comprising DS and FR regions)
sequences were obtained from vectors generously provided by
Prof. Bill Sugden (Reisman et al., 1985; Kirchmaier et al., 1995).
The EBNA-1 gene was amplified via PCR whilst adding XbaI and
AgeI restriction sites at the 5′ and 3′ end, respectively, to clone
into either the eGFP or GS containing vectors as described above.
Individual FR and DS sequences were based on the vectors
provided whilst fragments were generated via commercial
synthesis of the appropriate sequences (GeneART, Invitrogen,
United States) where BamHI and SalI restriction sites were added
to facilitate cloning. A vector containing the GS (GLUL), EBNA-1
and NDPK-A genes was generated to enable cell line engineering
of all three components simultaneously.
A gene sequence for expression of a modified version of the
SARS-CoV-2 Spike (S) protein was also synthesised commercially
(GeneART Invitrogen, United States). This modified version was
generated in line with the sequence from Wrapp et al. (2020)
where the transmembrane domain has been removed and proline
residues introduced to improve stability and remove cleavage
sites which are natively sensitive to proteolytic cleavage. The
native signal sequence present at the N-terminal of the S protein
was substituted for a mammalian signal sequence routinely
employed in Lonza’s expression vectors to facilitate efficient
secretion and reliable sequence cleavage via signal peptidase
in CHO cells. Finally, a His-tag (8 X His) was added to the
C-terminus to enable western blot analysis and purification using
an anti-His antibody. This modified S protein gene was cloned
into the transient vector format described above which contained
the oriP elements.
Cell Culture and Cell Line Construction
Lonza CHOK1SV and CHOK1SV GS-KO R© host cells were
routinely maintained in CD-CHO medium (Thermo Fisher
Scientific) supplemented with 6 mM L-glutamine. Transfection
of pDNA vectors encoding the gene for GS (GLUL) into
CHOK1SV or CHOK1SV GS-KO R© host cells were achieved
by electroporation using a BIORAD GenePulser Xcell
electroporator. 1 × 107 viable cells in 700 µL of CD-CHO
(Gibco) medium with 20 µg of DNA when only a single vector
was transfected (40 µg total linear pDNA was used for co-
transfections, 20 µg of each plasmid) was placed in a 0.4 cm
BIORAD electroporation cuvette and the exponential protocol
was applied using 300 V and 900 µF settings using a BIORAD
electroporator. After 24 h recovery in glutamine-free CD-CHO
medium, cell pools were selected in glutamine-free CD-CHO
medium containing a final concentration of 25 µM methionine
sulphoximine (MSX). Cells were sub-cultured every 3–4 days as
necessary and seeded at 0.2 × 106 viable cells/mL in a 125 mL
Erlenmeyer flask containing a total volume of 20 mL. Cultures
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 3 June 2021 | Volume 9 | Article 679448
fbioe-09-679448 May 31, 2021 Time: 18:26 # 4
Budge et al. Enhanced Transient CHO Cell Expression
were incubated at 37◦C with shaking at 140 rpm under a 5% CO2
(v/v) gas environment. Cell concentrations and culture viabilities
were determined using a ViCell (Beckman Coulter) instrument.
Flow Cytometry Analysis
Cell samples from suspension cultures analysed by flow
cytometry were first centrifuged and resuspended in PBS.
Samples were then analysed on a FACScaliburTM instrument
(BD Biosciences) and fluorescence intensity measured for 10,000
events. Forward scatter (FSC) was measured using the E-1
amplifier and side scatter (SSC) was set to 465 (Au) whilst
FL1 recorded cells at 473 (Au); all settings were converted
to a logarithmic scale. Data obtained via flow cytometry
recorded both the percentage of cells exceeding a predetermined
fluorescence threshold to indicate whether cells had been
successfully transfected with eGFP expressing vectors and the
overall geometric mean fluorescence of all cells recorded.
Gating was applied such that Lonza CHOK1SV host cells
did not exceed the threshold, but cells transfected with eGFP
containing constructs did.
Western Blot Analysis
Western blot analysis was undertaken essentially as previously
described (Roobol et al., 2015). Briefly, SDS-PAGE was used
to resolve polypeptides from protein lysates or supernatant
samples that were subsequently transferred from the gel to a
nitrocellulose membrane. Following this, the membrane was
blocked for 30 min in a 5% (w/v) powdered milk solution made
up in 0.2% (w/v) Tween TBS. Anti-GFP 3E1 antibody produced
in mouse (Research Monoclonal Antibody Service, CRUK), anti-
β-actin antibody produced in mouse (Sigma A5441), anti-γ chain
antibody produced in rabbit (Sigma I976) and anti-His (Sigma
H1029) were the primary antibodies used. Subsequently, anti-
Mouse HRP peroxidase (Sigma A4416) and anti-Rabbit HRP
peroxidase (Sigma A6154) antibody conjugates were used as
secondary detection antibodies. Peroxidase activity on the blot
indicated the position of specific immobilised polypeptides on
the blot was revealed by chemiluminescence using Hyperfilm
ECL reagents (GE Healthcare). Quantitative densitometry was
undertaken using ImageJ software.
Octet Analysis
Supernatants were isolated post transfection from cells that
had been transfected with the model IgG4, cB72.3, containing
constructs and analysed using an Octet (Fortebio) instrument.
Fortebio IgG calibrator standards and protein A biosensors were
used to determine IgG concentrations.
Statistical Analysis
Experiments were undertaken in biological triplicate in all cases
by executing three independent transfections for each condition
assessed. Error bars represent one standard deviation of the
mean. A one way ANOVA and post hoc Tukey tests were used
to determine statistical significance where appropriate as stated
within figure legends.
FIGURE 1 | Vectors containing NDPK-A and Chx10 genes that include NLSs, complementary BSs or a combination of the two (vector components present on each
vector are indicated through ± below corresponding bars) were transiently electroporated into Lonza CHOK1SV cells and the subsequent fluorescence intensity
analysed at 24 and 48 h post transfection via flow cytometry. (A) The percentage of cells in the resulting transient populations exceeding a predetermined
fluorescence intensity threshold, and (B) the overall geometric mean fluorescence. All experiments were run in biological triplicate (n = 3) and conditions significantly
different from the control condition for each time point are indicated on the graph (p < 0.05). A one way ANOVA followed by a post hoc Tukey test was used to
establish statistical significance to a 95% confidence level. Error bars show ± one standard deviation.
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RESULTS
Assessment of Transient Expression of
the Genes for NDPK-A and Chx10 and
Complementary Consensus Binding
Sequences in CHOK1SV Cells
Expression vectors encoding eGFP in addition to either NDPK-
A or Chx10 genes that contain an NLS, the consensus
binding sequence (BS) or a combination of the two were
transfected into Lonza’s CHOK1SV cells and analysed by flow
cytometry (Figure 1). Both the percentage of cells exceeding
a predetermined baseline background fluorescence intensity
threshold (from cells not expressing eGFP) and the overall
mean fluorescence values were recorded at 24 and 48 h
post transfection. The inclusion of the NDPK-A gene on the
expression vector resulted in an increase in the number of cells
exceeding the fluorescence intensity after both 24 and 48 h
time points (Figure 1A). Furthermore, there was a higher mean
fluorescence from the transient population transfected with the
NDPK-A NLS containing gene alone when compared to the
control after 48 h (Figure 1B). Interestingly, the transfection
of NDPK-A construct alone did not significantly increase
the percentage of cells exceeding the fluorescence threshold
(Figure 1A) but resulted in a 2-fold increase in overall mean
fluorescence after 48 h (Figure 1B). A combination of the NDPK-
A NLS containing gene construct and BS together resulted
in a small increase in the percentage of cells exceeding the
fluorescence threshold compared to the control and a statistically
significant increase in the overall geometric mean fluorescence
value, but this increase was not as substantial as when either
component was included alone.
Inclusion of the Chx10 gene sequence containing an NLS
resulted in an increased percentage of cells exceeding the
fluorescence intensity threshold after 24 h but this was not the
case at the 48 h time point (Figure 1A). Furthermore, this did not
translate to a significantly increased geometric mean fluorescence
at either time point measured (Figure 1B). The inclusion of the
Chx10 BS alone did not yield results that differed from the control
but inclusion of both the Chx10 gene and BS together resulted in
generally lower values. Indeed, the geometric mean fluorescence
values obtained using this vector and combination were less than
half of the control (Figure 1B).
Inclusion of EBNA-1 Gene and oriP
Derived Sequences Results in
Attenuated Cell Growth but Increased
Fluorescence in Transient CHOK1SV
Cultures
As described in the introduction, it has been shown that the
EBNA-1 gene can be used to enhance transient expression from
CHO cell systems. We therefore established the system here
by undertaking transfections with Lonza CHOK1SV cells using
pDNA containing either the truncated EBNA-1 gene, the minimal
oriP sequence, or a combination of the two on the same plasmid.
All vectors also contained the eGFP reporter gene to facilitate
population analysis using flow cytometry. Figure 2A shows the
viable cell numbers recorded over time post transfection. Whilst
transfection with constructs bearing oriP elements alone resulted
in an increase in cell numbers between 72 and 120 h, the
inclusion of the EBNA-1 gene alone resulted in a lower maximum
viable cell number on average compared with cells transfected
with the control vector. However, transfections carried out with
constructs containing both the EBNA-1 gene and oriP sequences
resulted in slower growth during exponential phase and lower
overall viable cell numbers during stationary phase, but survived
longer than cultures transfected with other plasmids.
Samples were also taken at the same time as those used for
viable cell number determination in order to evaluate eGFP
expression in transient populations by flow cytometry. The
inclusion of one or both of the EBNA-1 gene and oriP elements
resulted in an increased percentage of cells exceeding the pre-
determined fluorescence intensity threshold (Figure 2B) and an
increase in the overall geometric mean fluorescence (Figure 2C).
Moreover, the inclusion of the vector containing both EBNA-
1 and oriP sequences resulted in a 10-fold increase in the
geometric mean fluorescence at 48 h post transfection compared
to the control and consistently produced the highest geometric
mean fluorescent values throughout culture of the combinations
investigated in this section.





We next looked to combine the nuclear shuttling protein
expression of NDPK-A with the EBNA-1 based technology into
CHOK1SV cells to determine if this could deliver transient
expression beyond the capacity of either component individually.
As such, different combinations of the eGFP-control, NDPK-
A NLS and EBNA-1/oriP transient vectors were co-transfected
into the Lonza CHOK1SV host cells and the resulting transient
populations assessed by flow cytometry. We did not use
vectors with the BS on the recombinant (eGFP) vector as the
results in section “Assessment of Transient Expression of the
Genes for NDPK-A and Chx10 and Complementary Consensus
Binding Sequences in CHOK1SV Cells” suggested this did not
improve expression over using the NDPK-A gene alone. The
observed results confirm the data previously described when
these approaches were implemented individually (Figures 1, 2).
Specifically, the transfection of the NDPK-A harbouring vector
resulted in a modest increase in the percentage of cells exceeding
a fluorescence intensity threshold and inclusion of EBNA-1 and
oriP components on the transient vector resulted in a greater
increase in both the percentage of cells exceeding the fluorescence
intensity threshold and the overall geometric mean fluorescence
values (Figures 3A,B). Co-transfection of the NDPK-A and
EBNA-1/oriP containing vectors simultaneously resulted in the
highest percentage of cells exceeding the fluorescence intensity
threshold and overall geometric mean fluorescence. These data
show that whilst both technologies can be applied individually to
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FIGURE 2 | Vectors containing a truncated EBNA-1 gene, complementary oriP elements or a combination of the two were transiently electroporated in Lonza
CHOK1SV cells and analysed every 24 hours post transfection for 216 hours. X = control (eGFP only), n = oriP, s = EBNA-1,  = EBNA-1/oriP. (A) Viable cell
number of CHOK1SV cells post transfection with the described constructs, (B) flow cytometry obtained values showing the percentage of cells of transient
populations exceeding a predetermined fluorescence threshold, and (C) the overall mean fluorescence, were recorded. Error bars show ± one standard deviation.
All experiments were carried out in biological triplicate (n = 3).
improve transient transfection processes, when these approaches
are employed simultaneously this delivers transient expression
beyond that observed when either is used individually.
Stable Engineering of Lonza CHOK1SV
GS-KO Cells to Overexpress NDPK-A




Considering the increased transient expression of GFP when
utilising the combined NDPK-A and EBNA-1 mediated
extrachromosomal maintenance technologies, Lonza CHOK1SV
GS-KO R© cells were engineered to either stably overexpress the
NDPK-A NLS containing gene, express the truncated EBNA-1
gene, or both. To achieve this, vectors containing these and the
GS selection marker gene were used to generate stable pools
expressing either NDPK-A alone, truncated EBNA-1 alone, or
both as described in “Materials and Methods” section.
Transient transfections were carried out via electroporation
on these cell pools with a vector bearing the eGFP gene
alone or the eGFP gene and the oriP units (FR and DS).
The viable cell concentrations of the resulting transient
cultures were determined every 48 h for 192 h (Figure 4).
As observed in transient experiments (Figure 2A), the
inclusion of the EBNA-1 gene resulted in slowed growth
during exponential phase. However, EBNA-1 expressing
pools had the highest viable cell concentrations 192 h post
transfection compared to the control in the case of both vectors
transiently transfected. Interestingly, EBNA1/NDPK-A pools
declined at a faster rate than the control when transfected
with the oriP containing construct in comparison to other
pools (Figure 4B).
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FIGURE 3 | Co-transfections were performed with Lonza CHOK1SV cells using different combinations of control (eGFP alone), NDPK-A NLS and EBNA1/oriP
vectors. X = control;  = NDPK-A NLS and control; n = EBNA-1/oriP and control, s = EBNA-1/oriP and NDPK-A NLS (40 µg total DNA was used for each
transfection, comprising 20 µg of each specified construct, except in the control samples where 40 µg of the control plasmid was transfected). Flow cytometry was
used to assess the transient populations at different time points post transfection to ascertain (A) the percentage of cells exceeding a predetermined fluorescence
threshold, and (B) the overall geometric mean fluorescence. Error bars show ± one standard deviation. All experiments were carried out in biological triplicate (n = 3).
FIGURE 4 | Viable cell number in Lonza CHOK1SV GS-KO cells engineered to overexpress NDPK-A, express EBNA-1 or both (control pools were generated using
an empty construct) post-transfection with eGFP containing vectors. (A) Shows viable cell numbers of transient cultures transfected with a vector containing eGFP
alone (X = Control, # = NDPK-A,  = EBNA1 and M = NDPK-A & EBNA1 cell pools). (B) Shows viable cell numbers of transient cultures transfected with a vector
containing eGFP and oriP elements (X = Control,  = NDPK-A, n = EBNA1 and s = NDPK-A and EBNA1 cell pools). Error bars show ± one standard deviation. All
experiments were carried out in biological triplicate (n = 3).
Flow cytometry was used to evaluate the transient eGFP
expression at the same time points in the stably engineered CHO
cell pools (Figure 5). NDPK-A engineered cell pools yielded the
highest percentage of cells exceeding the fluorescence intensity
threshold whilst the EBNA-1 cell pools consistently produced the
lowest regardless of the presence of oriP elements in the transient
construct (Figures 5A,B). Furthermore, EBNA-1 expressing
pools gave the lowest overall geometric mean fluorescence values
across all measured time points, whilst EBNA-1/NDPK-A pools
outperformed pools that only expressed EBNA-1 (Figures 5C,D).
Relative eGFP protein levels were also determined using
western blot analysis (Figure 6). Lysate samples were obtained
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FIGURE 5 | Flow cytometry analysis of Lonza CHOK1SV GS-KO cells engineered to overexpress NDPK-A, express EBNA-1 or both (control pools were generated
using an empty construct) post-transfection with eGFP containing vectors. (A) Shows the percentage of cells exceeding a fluorescent intensity threshold in transient
cultures transfected with a vector containing eGFP alone (X = Control, # = NDPK-A,  = EBNA1 and M = NDPK-A and EBNA1 cell pools). (B) Shows the
percentage of cells exceeding a fluorescent intensity threshold in transient cultures transfected with a vector containing eGFP and oriP (X = Control,  = NDPK-A,
n = EBNA1 and s = NDPK-A and EBNA1 cell pools). (C) Shows the overall geometric mean fluorescence of transient cultures transfected with a vector containing
eGFP alone (X = Control, # = NDPK-A,  = EBNA1 and M = NDPK-A & EBNA1 cell pools). (D) Shows the overall geometric mean fluorescence of transient cultures
transfected with a vector containing eGFP and oriP (X = Control,  = NDPK-A, n = EBNA1 and s = NDPK-A and EBNA1 cell pools). Error bars show ± one
standard deviation. All experiments were carried out in biological triplicate (n = 3).
at the same time points as those taken for analysis by flow
cytometry. The western blot analysis of these samples are shown
in Figure 6A, which are a representative of blots analysed in
triplicate for all time points. Figure 6B reports the densitometry
analysis of western blots of cell lysates harvested at 192 h
post-transfection. Overexpression of the NDPK-A gene in the
Lonza CHOK1SV GS-KO cell pools resulted in enhanced
recombinant eGFP yields upon transient transfection with both
the eGFP or eGFP/oriP vectors that was evident by the increased
band intensities observed. This trend was consistent across all
time points analysed. Conversely, samples from EBNA-1 only-
expressing pools showed less intense eGFP bands compared
to the control, although the inclusion of oriP elements in
the transient vector showed moderate enhancement in these
cells. Both these trends were consistent with the previously
reported flow cytometry data (Figure 5). A marked increase
in relative eGFP yields was evident across all time points
when EBNA1/NDPK-A expressing cell pools were transiently
transfected with the oriP-containing vector. Not only did
these cells show an initial increase in relative eGFP levels at
48 h post transfection, an approximate 10-fold increase in
expression levels was still evident at 192 h post-transfection
(Figure 6B). Furthermore, the comparatively low levels of eGFP
observed upon transfection of the vector comprising eGFP
alone in EBNA1/NDPK-A expressing cell pools highlights the
requirements of the oriP components in the transient vector.
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FIGURE 6 | Analysis of Lonza CHOK1SV GS-KO cells engineered to overexpress NDPK-A, express EBNA-1 or both (control pools were generated using an empty
construct) post-transfection with eGFP containing vectors. (A) Shows western blot analysis of transient cultures transfected with a vector containing eGFP alone or
an eGFP/oriP vector (denoted by “oriP” on the figure). (B) Shows relative eGFP abundance from lysates of transient cultures (described above) harvested at 192 h
post-transfection. Densitometry analysis was carried out using ImageJ on western blots run in biological triplicate where β-actin was used as a loading control for
normalisation. A one way ANOVA test followed by post hoc Tukey test was carried out on densitometry data. Conditions which do not share a letter are statistically
different at the 95% confidence level. Error bars show ± one standard deviation. All experiments were carried out in biological triplicate (n = 3).
FIGURE 7 | Viable cell number of Lonza CHOK1SV GS-KO cells engineered to overexpress NDPK-A, express EBNA-1 or both (control pools were generated using
an empty construct) post-transfection with vectors containing genes for a model IgG4 mAb. (A) Shows viable cell numbers of transient cultures transfected with a
vector containing the mAb genes alone (X = Control, # = NDPK-A,  = EBNA1 and M = NDPK-A and EBNA1 cell pools). (B) Shows viable cell numbers of transient
cultures transfected with a vector containing mAb genes and oriP elements (X = Control,  = NDPK-A, n = EBNA1 and s = NDPK-A and EBNA1 cell pools). Error
bars show ± one standard deviation. All experiments were carried out in biological triplicate (n = 3).
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FIGURE 8 | Analysis of Lonza CHOK1SV GS-KO cells engineered to overexpress NDPK-A, express EBNA-1 or both (control pools were generated using an empty
construct) post-transfection with vectors containing genes for a model IgG mAb. (A) Shows western blot analysis of transient cultures transfected with a vector
containing mAb genes alone or a mAb/oriP vector (denoted by “oriP” on the figure). (B) Shows relative eGFP abundance from lysates of transient cultures (described
above) harvested at 192 hours post-transfection. Quantification of IgG mAb was carried out using Octet analysis. A one way ANOVA test followed by post hoc Tukey
test was carried out on titre data (B,C). Conditions which do not share a letter are statistically different at the 95% confidence level. Error bars show ± one standard
deviation. All experiments were carried out in biological triplicate (n = 3).
Stable Expression of NDPK-A and
EBNA-1 in CHO Cells and Inclusion of
oriP Elements on Transient Vectors
Enhances Production of a Model IgG4
Molecule and the SARS-CoV-2 Spike
Protein
Since the simultaneous introduction of EBNA-1 and NDPK-
A into CHOK1SV GS-KO cells proved effective in enhancing
expression of an eGFP reporter, the system was evaluated using
an industrially relevant model monoclonal antibody, an IgG4
molecule (cB72.3). Transient transfections were carried out
using vectors that contained the genes necessary for expression
of the IgG where the oriP elements were either included
or excluded (Figures 7, 8). Viable cell concentrations were
recorded every 48 h post transfection (Figure 7). Cell pools
engineered to express EBNA-1 alone showed lower viable cell
numbers when compared to the control host pools regardless
of whether the transient vector included the oriP elements or
not. This observation is consistent with the previously described
data where engineered cell pools were transfected with eGFP
containing vectors (Figure 4).
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Supernatants from batch culture were harvested every
48 h for 192 h post transfection and assessed using western
blot (Figure 8A) and Octet Protein A analysis in order to
determine quantity of IgG4 secreted into culture medium
(Figure 8B) and to calculate pool productivity (Figure 8C). The
inclusion of oriP elements on the expression vector resulted
in a general increase in the concentration of IgG4 observed,
and this was the case for all cell pools analysed. However,
the inclusion of the oriP elements resulted in a far greater
increase in IgG4 volumetric product concentration than the
control vector in both EBNA1 and EBNA-1/NDPK-A cell
pools; approximately an 8-fold increase in product titre was
observed in these pools in comparison to <2-fold increase
observed in the control cell pools (Figure 8B). Moreover,
transfections with the IgG4-only (no oriP) vector resulted in
a significantly lower titre in EBNA1 and EBNA1/NDPK-A cell
pools compared to the control.
The NDPK-A overexpressing cell pool showed higher specific
productivity than the control when transfected with the IgG4-
only vector (Figure 8C) but this did not result in improved
volumetric productivity (Figure 8B) due to the lower viable
cell concentrations achieved (Figure 7A). Furthermore, the
overexpression of NDPK-A in combination with the introduction
of EBNA1 did not result in significantly greater IgG4 product
yields than what was achieved in the pool engineered with
EBNA1 alone (Figure 8B) as previously observed with the eGFP
containing constructs (Figure 6).
We then applied the system to the expression of the SARS-
CoV-2 Spike or S protein which is a large glycosylated protein that
is difficult to express (Johari et al., 2021). Viral entry is mediated
by binding of the spike (S) protein that protrudes from the surface
of the pathogen and binds to angiotensin-converting enzyme 2
(ACE2) present on the surface of host cells (Lan et al., 2020). The
S protein is a key target for both vaccine design and diagnostics
due its central role in facilitating infection and its presence on the
outer membrane of the virus means it is accessible to the immune
system. The S protein is a multi-domain and heavily glycosylated
protein and production of material with similar attributes is
crucial for effective application of the S protein as a part of a
vaccine or diagnostics. CHO cells are capable of generating such
material with suitable properties (Johari et al., 2021). Therefore,
following successful implementation of NDPK-A and EBNA-1
based technologies in CHO cells to generate enhanced yields of
reporter and model mAb proteins, we employed this platform
to generate the SARS-CoV-2 S protein that had been engineered
to remove the native transmembrane domain and proteolytic
cleavage sites (Wrapp et al., 2020).
Figure 9A shows western blot analysis of supernatants,
harvested 8 days post-transfection, of the engineered CHO cell
pools (control, NDPK-A, EBNA-1, or EBNA-1/NDPK-A) grown
under batch culture conditions and transiently transfected with
an expression vector containing the modified SARS-CoV-2 S
protein and minimal oriP elements (FR and DS). The bands
observed were revealed by probing the blot with an anti-
His antibody (Sigma H1029) and densitometry carried out on
bands to determine the relative quantities of modified S protein
generated using the different cell pools. The cell pools which
FIGURE 9 | Analysis of Lonza CHOK1SV GS-KO cells engineered to
overexpress NDPK-A, express EBNA-1 or both (control pools were generated
using an empty construct) post-transfection with vectors containing the gene
for a SARS nCov Spike and the oriP elements. (A) Shows western blot
analysis of supernatants harvested 8 days post-transfection using an anti-His
tag antibody, whilst figure (B) shows relative band intensities as determined
using densitometry. A one way ANOVA test followed by post hoc Tukey test
was carried out on densitometry data. Conditions which do not share a letter
are statistically different at the 95% confidence level. Error bars show ± one
standard deviation. All experiments were carried out in biological triplicate
(n = 3).
were engineered to overexpress either NDPK-A or introduce
EBNA-1 independently produced less modified S protein than
the control which was not engineered with either gene. However,
the cell pool which was engineered to overexpress NDPK-A and
EBNA-1 simultaneously resulted in a 1.8-fold increase in Spike
protein yields on average than the non-engineered control cell
pool (Figure 9B).
DISCUSSION
The advantages of using TGE to rapidly and cost effectively
produce material for pre-clinical studies has long been
recognised, but development of transient expression platforms
capable of producing high yields of efficacious material has
gained increasing focus in recent years in light of the increased
number of products entering clinical trials. Furthermore, it is
beneficial to employ the same host cell line for both transient
and stable production so that the material generated for drug
candidate evaluation in transient experiments is representative
of the final stably produced product. Indeed, recent advances in
CHO cell TGE technologies and associated enhanced product
yields has led to questions around whether such transient
platforms could be used to generate specific materials for clinical
phase 1 trials or in rapid response to pandemics (Gutiérrez-
Granados et al., 2018). TGE is typically used for smaller scale
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production where the speed of production is key. There are
relatively fewer reports of large scale transient production due
to the high cost of the process in comparison to the protein
yield obtained (Baldi et al., 2007). By improving transient yields,
the cost efficiency of the process is increased but the overall
yields obtained are not yet comparable to those generated
using stable production technologies, although for “easier”
to express standard monoclonal antibodies yields in the g/L
have been reported.
A key aspect of transient systems is the delivery of DNA
into the nucleus and then the subsequent maintenance of this
within the nucleus. Although there have now been a number
of studies focussed on improving nuclear maintenance, there
have been few, if any advances in improving DNA entry into
the nucleus. Indeed, import of DNA across the nuclear barrier
is poorly understood, although it has been hypothesised that this
process could be either passive, i.e., when the nuclear membrane
is compromised during cell division, or active through the NPC.
Whilst the exact weight of contribution of these two mechanisms
has not been determined, nuclear import of pDNA has been
shown to be maximal in actively proliferating cells (Edwards
and Passineau, 2015). Moreover, other factors may contribute
to the mechanism or efficiency of nuclear entry, e.g., size of
pDNA and whether the pDNA is delivered as part of a polyplex
(as for example, in chemically-based transfection methods) or
transfected as naked DNA (in physically based transfection
methods such as electroporation). Nonetheless, it is thought
that entry of pDNA into the nucleus is a potential limitation
in transient expression. Here, we have described a method for
improved nuclear import through the NPC by overexpressing
either NDPK-A or Chx10 transcription factors in CHO cells.
These proteins have previously been shown to facilitate nuclear
import in non-dividing HeLa cells (Munkonge et al., 2009). The
inclusion of a consensus BS on the transient plasmid did not
necessarily improve the CHO cell transient system. In fact, when
the Chx10 NLS and BS were both included on the transient vector
there was a significant decrease in both the percentage of cells
above a fluorescence intensity threshold and mean fluorescence
intensity. The NDPK-A and Chx10 BSs were previously shown
to improve nuclear import when included on pDNA adjacent to
the SV40 DTS. In this study, the Chx10 BS did not function as
a traditional DTS when positioned away from an existing DTS
on the pDNA suggesting that this consensus sequence cannot
be used as a DTS independently. The inclusion of the NDPK-
A NLS and BS simultaneously did not show any advantage over
including either independently.
The inclusion of the NDPK-A gene alone (without BS)
improved both the percentage and overall fluorescence intensity
following transient transfection with an eGFP containing plasmid
when transiently and stably employed. In addition to its function
in nuclear import, NDPK-A also plays a major role in the transfer
of a phosphate group from ATP to a nucleoside diphosphate
other than ATP; such as the synthesis of GTP from GDP (Boissan
et al., 2014). In a nuclear import context, GTP is required to
supply energy for the migration of cytoplasmic cargo through the
nuclear pore complex into the nucleus (Dzeja and Terzic, 2003).
Overexpression of the NDPK-A gene may therefore upregulate
the rate at which molecules can traverse the nuclear membrane
due to improved availability of energy from GTP. NDPK-A also
impacts cell proliferation and is functional as a transcription
factor (Sharma et al., 2018) and thus, although differences
observed in reporter protein expression levels are likely due to
increased transfection efficiencies and delivery of pDNA into the
nucleus, it is possible that the increase observed may be owed, at
least in part, to these other roles of NDPK-A.
Introduction of the Epstein Barr derived EBNA-1 protein
and the essential oriP (FR and DS) sequences have previously
proved successful in inducing extrachromosomal maintenance
in mammalian cells (Längle-Rouault et al., 1998; Van
Craenenbroeck et al., 2000; Yates et al., 2000; Backliwal
et al., 2008; Jäger et al., 2013; Daramola et al., 2014) although
this approach has generally been more successful in human cells
such as human embryonic kidney (HEK) cells than in CHO cells
(Kunaparaju et al., 2005). However, as described above, reports
have suggested that the rate of nuclear import of plasmid DNA
is a potential bottleneck in hosts engineered to introduce the
EBNA-1 driven extrachromosomal system (Carpentier et al.,
2007). Our data support this, but further, also suggests that a
decrease in the rate of nuclear import of plasmid DNA may be
linked to the reduced growth observed when the EBNA-1 gene is
introduced in the Lonza CHOK1SV or CHOK1SV GS-KO cells
either transiently or stably, respectively. Reduced growth, and
hence proliferation, will result in less frequent breakdown of the
nuclear envelope during M phase of the cell cycle and therefore
a lower passive rate of nuclear entry of plasmid DNA during
transfection. Furthermore, the introduction of the EBNA-1
extrachromosomal maintenance system may place additional
metabolic burden upon the CHO cell host and could account
for observed reduced growth. The data presented here shows
that cells only expressing exogenously added EBNA-1 gene have
compromised growth and consistently decreased expression
of both eGFP and an IgG4 molecules in the absence of the
oriP elements.
NDPK-A and EBNA-1 based technologies were introduced
simultaneously following their successful application
independently. Both transient and stable employment of these
approaches proved effective in improving eGFP yields. Following
successful transient transfection of CHOK1SV cells with
expression vectors encoding eGFP, EBNA-1, NDPK-A and oriP,
transient transfection of CHOK1SV GS-KO pools co-expressing
EBNA-1 and NDPK-A with expression vectors encoding oriP
and eGFP, led to a 10-fold increase in eGFP abundance compared
to the control. Whilst the NDPK-A/EBNA-1 system was able to
improve transient yields of the IgG4 molecule compared to the
non-engineered control, no improvement was observed beyond
that observed when the EBNA-1 system was implemented alone.
When employed independently, the NDPK-A driven technology
was able to modestly enhance IgG4 productivity compared to the
control. Collectively these data suggest it is likely that transient
expression yields are determined by different bottlenecks
dependant on the molecule being expressed and transfection
efficiency may be at least partially, impacted by the size of the
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vector as previously reported (Kreiss et al., 1999; Hornstein et al.,
2016). However, when we used the system to express another
recombinant protein from a construct close in size to the IgG4
construct, that for the S protein (Supplementary Figure 1), we
did see an increase in transient expression suggesting size is
not a major constraint. Indeed, when the EBNA-1 and NDPK-
A mediated technologies were employed to generate a modified
version of the SARS-CoV-2 S protein the cells engineered with
the technologies separately (i.e., EBNA-1-CHO and NDPK-A-
CHO cells) generated less S protein than the control. However,
the cells engineered to contain both technologies (EBNA-
1/NDPK-A-CHO) gave a 1.8-fold increase in the expression
of secreted S-protein compared to the control. This provides
further evidence that these technologies can be implemented
simultaneously to achieve higher secretory recombinant protein
yields of molecules of various different formats whilst the same
technologies implemented independently did not always generate
more material. The recombinant production of S protein is of
particular interest since it is a key component in manufacturing
diagnostics for SARS-CoV-2 and a key target for development
of COVID-19 vaccines (Pollet et al., 2021). By employing the
TGE system outlined here, more S protein was produced than
the original CHO host transient system, advantageous for rapid
generation of material for diagnostics, antibody development and
for evaluation of potential vaccine candidates. This is therefore an
example of how this TGE platform could be utilised to accelerate
vaccine and biotherapeutic discovery timelines.
CONCLUSION
In conclusion, we have shown that EBNA-1 and NDPK-A based
technologies can be employed independently or simultaneously
to enhance transient yields from CHO cells, and particularly of
the difficult to express SARS-CoV-2 S protein. The increase in
secretory productivity from these technologies is dependent on
the molecule of interested being transiently expressed which is
not surprising given different molecules are known to present
different cellular challenges and bottlenecks for optimal yields.
Nevertheless, this study shows that a combined approach of
nuclear DNA maintenance coupled with enhanced plasmid DNA
nuclear entry is a promising concept to further enhance the
transient yields of recombinant protein that can be achieved from
CHO cells and can be used to obtain higher yields of complex
glycosylated proteins such as the S protein.
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